IBOV 176,723.62 ▼ 0.46% IPSA 10,916.70 ▼ 0.84% IPC MEX 66,266.01 ▼ 1.54% MERVAL 3,319,522 ▼ 1.78% COLCAP 2,283.28 ▼ 0.60% BVL PERÚ 57,575.02 — — USD/BRL5.08▲ 0.50% USD/MXN17.51▲ 0.68% USD/CLP945.00▲ 1.00% USD/COP3,200▼ 0.84% USD/PEN3.40▼ 0.08% USD/ARS1,488▲ 0.38% USD/UYU40.14▲ 1.16% USD/PYG6,025▲ 1.20% USD/BOB11.03▲ 3.57% USD/DOP 58.00 — 0.00% USD/CRC451.03▲ 2.18% USD/GTQ7.62▲ 2.29% USD/HNL26.74▲ 0.88% USD/NIO36.62▲ 0.31% USD/VES740.37▲ 0.46% USD/PAB1.00— 0.00% USD/BZD2.00— 0.00% USD/JMD157.69▲ 0.48% USD/TTD6.73▲ 1.11% EUR/BRL5.78▼ 0.26% BRENT 100.00 ▲ 6.30% WTI 91.55 ▲ 5.44% IRON ORE 161.91 — — COPPER 6.33 ▼ 1.88% GOLD 4,049 ▼ 2.36% SILVER 58.04 ▼ 3.31% SOY 1,246 ▲ 1.03% CORN 488.50 ▲ 5.74% WHEAT 698.25 ▼ 1.06% COFFEE 310.75 ▼ 1.86% SUGAR 14.68 ▼ 0.41% ORANGE JUICE 145.50 ▼ 3.19% COTTON 81.53 ▲ 2.08% COCOA 5,367 ▲ 0.73% BEEF 221.48 ▼ 0.77% CATTLE 340.13 ▼ 0.31% LITHIUM 69.02 ▲ 0.03% PETR4 42.95 ▲ 0.87% VALE3 75.68 ▲ 0.77% ITUB4 42.56 ▼ 0.79% BBDC4 18.72 ▼ 1.32% ABEV3 15.92 ▼ 1.30% BBAS3 20.93 ▼ 0.76% B3SA3 15.65 ▼ 1.57% WEGE3 45.67 ▼ 2.29% PRIO3 60.54 ▲ 1.29% SUZB3 42.43 ▼ 0.54% RENT3 37.14 — 0.00% AZZA3 17.05 ▼ 4.27% CSAN3 3.90 ▼ 0.51% RAIZ4 0.27 — 0.00% PCAR3 2.87 ▲ 4.36% GMAT3 3.87 ▼ 1.02% PSSA3 55.18 ▼ 0.49% CVCB3 1.31 ▲ 3.15% POSI3 3.67 ▼ 0.81% SLCE3 13.77 ▼ 1.36% NATU3 8.56 ▼ 1.38% BRKM5 6.17 ▲ 1.65% RANI3 7.93 ▼ 0.88% CSNA3 5.30 ▼ 1.49% CMIN3 5.83 ▼ 0.17% USIM5 8.49 ▼ 1.85% GGBR4 24.06 — 0.00% ENEV3 25.70 ▼ 1.04% CPFE3 46.22 ▼ 1.05% CMIG4 11.19 ▼ 0.18% EQTL3 39.02 ▼ 0.84% LREN3 13.37 ▼ 1.26% VIVT3 34.70 ▼ 1.92% RAIL3 13.96 ▲ 2.35% KLABIN 17.66 ▼ 1.51% RAIA DROGASIL 18.19 ▼ 0.55% RDOR3 33.67 ▼ 2.38% HAPV3 10.47 ▼ 8.08% FLRY3 16.58 ▼ 0.42% SMTO3 15.71 ▼ 2.12% UGPA3 33.39 ▲ 1.71% VBBR3 35.60 ▲ 1.77% BBSE3 42.40 ▼ 0.42% BPAC11 56.30 ▼ 1.26% CURY3 29.62 ▼ 1.92% AERI3 2.02 ▼ 1.46% VIVARA 21.45 ▼ 0.46% COMPASS 25.08 ▲ 1.09% VAMOS 3.21 ▼ 0.62% SANB11 26.63 ▼ 1.19% ASAI3 8.02 ▼ 4.52% SBSP3 29.00 ▼ 0.99% WALMEX 47.27 ▼ 2.84% GMEXICO 208.35 ▼ 3.10% FEMSA 222.31 ▼ 2.38% CEMEX 21.48 ▼ 3.11% GFNORTE 189.00 ▼ 1.37% BIMBO 59.08 ▼ 2.02% TELEVISA 9.79 ▼ 0.31% AMX 22.84 ▲ 0.66% GAP 375.37 ▼ 0.36% ASUR 269.84 ▼ 1.35% OMA 227.18 ▼ 0.66% KOF 179.34 ▼ 1.81% GRUMA 268.11 ▼ 4.40% KIMBER 39.20 ▲ 0.98% SQM-B 65,499 ▲ 0.68% COPEC 6,260 ▼ 4.43% BSANTANDER 80.00 ▲ 0.19% FALABELLA 6,058 ▲ 0.26% ENELAM 85.00 ▲ 0.56% CENCOSUD 1,968 ▼ 2.08% CMPC 1,051 ▼ 1.78% BANCO CHILE 190.72 ▼ 1.44% LATAM AIR 23.50 ▼ 2.45% YPF 82,475 ▼ 0.03% GGAL 7,945 ▼ 3.99% PAMPA 5,630 ▲ 0.09% TXAR 680.00 ▲ 1.80% ALUAR 982.50 ▲ 0.87% TGS 9,995 ▲ 0.91% CEPU 2,420 ▲ 0.37% MIRGOR 16,725 ▼ 1.18% COME 42.53 ▼ 1.41% LOMA NEGRA 3,765 ▼ 1.18% BYMA 292.50 ▼ 1.02% TELECOM ARG 4,325 ▼ 2.15% ECOPETROL 16.33 ▼ 2.16% BANCOLOMBIA 86.79 ▲ 2.52% GRUPO AVAL 4.93 ▼ 2.18% CREDICORP 387.63 ▼ 1.53% SOUTHERN COPPER 182.22 ▼ 6.78% BUENAVENTURA 31.32 ▼ 2.40% MERCADOLIBRE 1,799 ▼ 0.03% NUBANK 14.19 ▼ 2.21% XP 16.83 ▼ 2.72% PAGSEGURO 9.46 ▼ 2.17% STONE 10.98 ▼ 3.35% GLOBANT 30.61 ▼ 0.20% TECNOGLASS 43.75 ▼ 3.26% GAP AIRPORT 215.45 ▼ 0.96% ASUR 269.84 ▼ 1.35% OMA AIRPORT 104.14 ▼ 1.15% AMX ADR 25.95 ▼ 0.65% FEMSA ADR 127.08 ▼ 2.93% CEMEX ADR 12.26 ▼ 3.62% PETROBRAS ADR 19.00 ▲ 0.58% VALE ADR 14.83 ▼ 0.13% ITAU ADR 8.35 ▼ 1.53% SANTANDER BR 5.36 ▼ 1.74% AMBEV ADR 3.09 ▼ 1.47% CSN 1.06 ▼ 2.75% GERDAU 4.77 — 0.00% LATAM ADR 49.79 ▼ 2.87% BTC 65,037 ▼ 1.61% ETH 1,872 ▼ 3.21% SOL 75.66 ▼ 2.88% XRP 1.11 ▼ 2.95% BNB 567.24 ▼ 0.62% ADA 0.17 ▼ 4.19% DOGE 0.07 ▼ 5.16% AVAX 6.24 ▼ 5.70% LINK 8.43 ▼ 2.24% DOT 0.81 ▼ 2.30% LTC 46.96 ▼ 0.24% BCH 209.80 ▼ 4.62% TRX 0.33 ▼ 0.09% XLM 0.18 ▼ 2.62% HBAR 0.07 ▼ 2.33% NEAR 1.89 ▲ 1.23% ATOM 1.42 ▼ 2.90% AAVE 95.38 ▼ 2.03% SELIC 14.25% EMBRAER 83.40 ▼ 0.47% EMBRAER ADR 65.47 ▼ 0.88% JBS 12.13 ▼ 0.98% JBS BDR 61.82 ▲ 0.03% MBRF3 15.59 ▼ 2.74% MBRFY 3.09 ▼ 3.13% INTER 5.46 ▼ 4.04% EGX 53,932 ▼ 0.11% USD/ZAR16.80▲ 2.46% USD/NGN 1,366 — 0.00% NIKKEI 64,579 ▼ 2.78% CSI300 4,702 ▼ 0.55% HSI 24,914 ▼ 1.18% NIFTY 23,870 ▼ 0.53% KOSPI 6,894 ▼ 2.86% JCI 6,315 ▼ 0.30% USD/JPY163.77▲ 0.38% USD/CNY6.76▼ 0.12% DAX 24,763 ▼ 1.56% CAC 8,299 ▼ 1.64% FTSE 10,639 ▼ 0.73% MIB 51,316 ▼ 2.80% IBEX 19,267 ▼ 1.55% STOXX 639.27 ▼ 1.18% EUR/USD1.14▼ 0.22% GBP/USD1.33▼ 0.44% SPX 7,408 ▼ 1.21% DJI 51,712 ▼ 0.97% NDX 28,455 ▼ 1.87% RUT 2,940 ▼ 0.67% TSX 35,193 ▼ 0.82% VIX 18.70 ▲ 12.38% USD/CAD1.41▼ 0.10% US10Y 4.7030 ▲ 0.99% IBOV 176,723.62 ▼ 0.46% IPSA 10,916.70 ▼ 0.84% IPC MEX 66,266.01 ▼ 1.54% MERVAL 3,319,522 ▼ 1.78% COLCAP 2,283.28 ▼ 0.60% BVL PERÚ 57,575.02 — — USD/BRL 5.08 ▲ 0.50% USD/MXN 17.51 ▲ 0.68% USD/CLP 945.00 ▲ 1.00% USD/COP 3,200 ▼ 0.84% USD/PEN 3.40 ▼ 0.08% USD/ARS 1,488 ▲ 0.38% USD/UYU 40.14 ▲ 1.16% USD/PYG 6,025 ▲ 1.20% USD/BOB 11.03 ▲ 3.57% USD/DOP 58.00 — 0.00% USD/CRC 451.03 ▲ 2.18% USD/GTQ 7.62 ▲ 2.29% USD/HNL 26.74 ▲ 0.88% USD/NIO 36.62 ▲ 0.31% USD/VES 740.37 ▲ 0.46% USD/PAB 1.00 — 0.00% USD/BZD 2.00 — 0.00% USD/JMD 157.69 ▲ 0.37% USD/TTD 6.73 ▲ 1.17% EUR/BRL 5.78 ▼ 0.26% BRENT 100.00 ▲ 6.30% WTI 91.55 ▲ 5.44% IRON ORE 161.91 — — COPPER 6.33 ▼ 1.88% GOLD 4,049 ▼ 2.36% SILVER 58.04 ▼ 3.31% SOY 1,246 ▲ 1.03% CORN 488.50 ▲ 5.74% WHEAT 698.25 ▼ 1.06% COFFEE 310.75 ▼ 1.86% SUGAR 14.68 ▼ 0.41% ORANGE JUICE 145.50 ▼ 3.19% COTTON 81.53 ▲ 2.08% COCOA 5,367 ▲ 0.73% BEEF 221.48 ▼ 0.77% CATTLE 340.13 ▼ 0.31% LITHIUM 69.02 ▲ 0.03% PETR4 42.95 ▲ 0.87% VALE3 75.68 ▲ 0.77% ITUB4 42.56 ▼ 0.79% BBDC4 18.72 ▼ 1.32% ABEV3 15.92 ▼ 1.30% BBAS3 20.93 ▼ 0.76% B3SA3 15.65 ▼ 1.57% WEGE3 45.67 ▼ 2.29% PRIO3 60.54 ▲ 1.29% SUZB3 42.43 ▼ 0.54% RENT3 37.14 — 0.00% AZZA3 17.05 ▼ 4.27% CSAN3 3.90 ▼ 0.51% RAIZ4 0.27 — 0.00% PCAR3 2.87 ▲ 4.36% GMAT3 3.87 ▼ 1.02% PSSA3 55.18 ▼ 0.49% CVCB3 1.31 ▲ 3.15% POSI3 3.67 ▼ 0.81% SLCE3 13.77 ▼ 1.36% NATU3 8.56 ▼ 1.38% BRKM5 6.17 ▲ 1.65% RANI3 7.93 ▼ 0.88% CSNA3 5.30 ▼ 1.49% CMIN3 5.83 ▼ 0.17% USIM5 8.49 ▼ 1.85% GGBR4 24.06 — 0.00% ENEV3 25.70 ▼ 1.04% CPFE3 46.22 ▼ 1.05% CMIG4 11.19 ▼ 0.18% EQTL3 39.02 ▼ 0.84% LREN3 13.37 ▼ 1.26% VIVT3 34.70 ▼ 1.92% RAIL3 13.96 ▲ 2.35% KLABIN 17.66 ▼ 1.51% RAIA DROGASIL 18.19 ▼ 0.55% RDOR3 33.67 ▼ 2.38% HAPV3 10.47 ▼ 8.08% FLRY3 16.58 ▼ 0.42% SMTO3 15.71 ▼ 2.12% UGPA3 33.39 ▲ 1.71% VBBR3 35.60 ▲ 1.77% BBSE3 42.40 ▼ 0.42% BPAC11 56.30 ▼ 1.26% CURY3 29.62 ▼ 1.92% AERI3 2.02 ▼ 1.46% VIVARA 21.45 ▼ 0.46% COMPASS 25.08 ▲ 1.09% VAMOS 3.21 ▼ 0.62% SANB11 26.63 ▼ 1.19% ASAI3 8.02 ▼ 4.52% SBSP3 29.00 ▼ 0.99% WALMEX 47.27 ▼ 2.84% GMEXICO 208.35 ▼ 3.10% FEMSA 222.31 ▼ 2.38% CEMEX 21.48 ▼ 3.11% GFNORTE 189.00 ▼ 1.37% BIMBO 59.08 ▼ 2.02% TELEVISA 9.79 ▼ 0.31% AMX 22.84 ▲ 0.66% GAP 375.37 ▼ 0.36% ASUR 269.84 ▼ 1.35% OMA 227.18 ▼ 0.66% KOF 179.34 ▼ 1.81% GRUMA 268.11 ▼ 4.40% KIMBER 39.20 ▲ 0.98% SQM-B 65,499 ▲ 0.68% COPEC 6,260 ▼ 4.43% BSANTANDER 80.00 ▲ 0.19% FALABELLA 6,058 ▲ 0.26% ENELAM 85.00 ▲ 0.56% CENCOSUD 1,968 ▼ 2.08% CMPC 1,051 ▼ 1.78% BANCO CHILE 190.72 ▼ 1.44% LATAM AIR 23.50 ▼ 2.45% YPF 82,475 ▼ 0.03% GGAL 7,945 ▼ 3.99% PAMPA 5,630 ▲ 0.09% TXAR 680.00 ▲ 1.80% ALUAR 982.50 ▲ 0.87% TGS 9,995 ▲ 0.91% CEPU 2,420 ▲ 0.37% MIRGOR 16,725 ▼ 1.18% COME 42.53 ▼ 1.41% LOMA NEGRA 3,765 ▼ 1.18% BYMA 292.50 ▼ 1.02% TELECOM ARG 4,325 ▼ 2.15% ECOPETROL 16.33 ▼ 2.16% BANCOLOMBIA 86.79 ▲ 2.52% GRUPO AVAL 4.93 ▼ 2.18% CREDICORP 387.63 ▼ 1.53% SOUTHERN COPPER 182.22 ▼ 6.78% BUENAVENTURA 31.32 ▼ 2.40% MERCADOLIBRE 1,799 ▼ 0.03% NUBANK 14.19 ▼ 2.21% XP 16.83 ▼ 2.72% PAGSEGURO 9.46 ▼ 2.17% STONE 10.98 ▼ 3.35% GLOBANT 30.61 ▼ 0.20% TECNOGLASS 43.75 ▼ 3.26% GAP AIRPORT 215.45 ▼ 0.96% ASUR 269.84 ▼ 1.35% OMA AIRPORT 104.14 ▼ 1.15% AMX ADR 25.95 ▼ 0.65% FEMSA ADR 127.08 ▼ 2.93% CEMEX ADR 12.26 ▼ 3.62% PETROBRAS ADR 19.00 ▲ 0.58% VALE ADR 14.83 ▼ 0.13% ITAU ADR 8.35 ▼ 1.53% SANTANDER BR 5.36 ▼ 1.74% AMBEV ADR 3.09 ▼ 1.47% CSN 1.06 ▼ 2.75% GERDAU 4.77 — 0.00% LATAM ADR 49.79 ▼ 2.87% BTC 65,037 ▼ 1.61% ETH 1,872 ▼ 3.21% SOL 75.66 ▼ 2.88% XRP 1.11 ▼ 2.95% BNB 567.24 ▼ 0.62% ADA 0.17 ▼ 4.19% DOGE 0.07 ▼ 5.16% AVAX 6.24 ▼ 5.70% LINK 8.43 ▼ 2.24% DOT 0.81 ▼ 2.30% LTC 46.96 ▼ 0.24% BCH 209.80 ▼ 4.62% TRX 0.33 ▼ 0.09% XLM 0.18 ▼ 2.62% HBAR 0.07 ▼ 2.33% NEAR 1.89 ▲ 1.23% ATOM 1.42 ▼ 2.90% AAVE 95.38 ▼ 2.03% SELIC 14.25% EMBRAER 83.40 ▼ 0.47% EMBRAER ADR 65.47 ▼ 0.88% JBS 12.13 ▼ 0.98% JBS BDR 61.82 ▲ 0.03% MBRF3 15.59 ▼ 2.74% MBRFY 3.09 ▼ 3.13% INTER 5.46 ▼ 4.04% EGX 53,932 ▼ 0.11% USD/ZAR 16.80 ▼ 0.12% USD/NGN 1,366 — 0.00% NIKKEI 64,579 ▼ 2.78% CSI300 4,702 ▼ 0.55% HSI 24,914 ▼ 1.18% NIFTY 23,870 ▼ 0.53% KOSPI 6,894 ▼ 2.86% JCI 6,315 ▼ 0.30% USD/JPY 163.77 ▲ 0.01% USD/CNY 6.7635 ▼ 0.05% DAX 24,763 ▼ 1.56% CAC 8,299 ▼ 1.64% FTSE 10,639 ▼ 0.73% MIB 51,316 ▼ 2.80% IBEX 19,267 ▼ 1.55% STOXX 639.27 ▼ 1.18% EUR/USD 1.1387 ▲ 0.04% GBP/USD 1.3321 ▲ 0.04% SPX 7,408 ▼ 1.21% DJI 51,712 ▼ 0.97% NDX 28,455 ▼ 1.87% RUT 2,940 ▼ 0.67% TSX 35,193 ▼ 0.82% VIX 18.70 ▲ 12.38% USD/CAD 1.4073 ▼ 0.05% US10Y 4.7030 ▲ 0.99%
since 2009
Friday, July 24, 2026

Brazil Covid-19

Brazil calls on EU for help in purchasing vaccines and medicines

By · April 16, 2021 · 6 min read

Daily Brief

The morning intel from across Latin America. Free.

By subscribing you agree to our privacy policy. We never share your email.

RIO DE JANEIRO, BRAZIL – The Brazilian ambassador to the European Union, Marcos Galvão, on Thursday, April 15th, advocated vaccination in the fight against the pandemic and asked for support from the European bloc to purchase more immunizers and medicines in short supply in the South American country. The appeal was made during a meeting of the European Parliament Delegation for relations with Brazil.

“Faced with the situation, our humanitarian, health and economic priorities need to focus on vaccines. There is no other way out of this disaster affecting everyone. It is a race against time to save many lives in Brazil and millions in the world,” said Galvão at the meeting called by members of the European Parliament to discuss the situation of the Covid-19 pandemic in Brazil.

The Brazilian ambassador to the European Union, Marcos Galvão recognized the seriousness of the crisis in the country. (Photo internet reproduction)
One-stop reference
Company Intelligence
Every listed company in Latin America — financials, ownership and structure for 1,450+ companies across 26 exchanges, in one place.
Browse the directory →
RT
Ask Rio Times
This story and the bigger picture.
Open the full Ask Rio Times →

Speaking about the vaccination campaign, Galvão said that the country is able to vaccinate 2.4 million people per day. “If there were enough Covid-19 vaccines available we could vaccinate our population faster,” he stressed.

The ambassador also said that the federal government would have signed contracts to purchase enough doses to immunize the entire Brazilian population throughout this year and argued that the slow vaccination experienced in the country is a common problem worldwide, which would be occurring partly due to delays in the delivery of vaccines and raw materials for their production.

Bolsonaro’s resistance

However, Galvão failed to mention Jair Bolsonaro’s resistance to signing contracts for the purchase of vaccines during the past year. Initially, the government bet all its chips on the immunizer developed by the Anglo-Swedish pharmaceutical company AstraZeneca and Oxford University, which have a partnership with Fiocruz. The president also tried to sabotage parallel initiatives of vaccination and fighting the disease by governors and mayors in response to his government’s inertia in the issue.

In October, the president categorically stated that he would not buy the Chinese Coronavac vaccine – in a clear clash with São Paulo governor João Doria (PSDB), who promoted the development of the Sinovac vaccine in partnership with the Butantan Institute. Currently, more than 80% of the doses applied in the country are Coronavac.

The vaccine developed by the American pharmaceutical company Pfizer and the German biotechnology company Biontech was at the center of a public fight between Pfizer and the Presidential Administration. For months, Bolsonaro criticized and refused to sign the contract offered by the company.

In his speech, Galvão acknowledged the current seriousness of the health crisis in the country and presented a panorama with the current pandemic numbers in Brazil, as well as data on the emergency aid, highlighting that despite the reduction in the value of the benefit for the round foreseen this year, the measure “will still be significant”. He also defended the Unified Health System (SUS) and called on the European Union’s support to acquire medicines, especially those used for patient intubation, and oxygen that are in short supply in the country.

Brazil is facing the worst moment of the coronavirus crisis, with an explosion in the number of cases that has led to the collapse of the health system in several states. Deaths from Covid-19 have also been rising in recent months and have been breaking constant daily records. The disease has killed over 361,000 people in the country.

Criticism from Members of the European Parliament

The federal management of the coronavirus crisis was criticized by MEPs during the debate. Since the beginning of the pandemic, Bolsonaro has downplayed the disease, which he even described as a minor flu in a television statement. He also advocated ineffective treatments and opposed the use of masks, confinement, and social distancing – measures considered fundamental by the World Health Organization (WHO) to contain virus transmission. The president also attended several events without masks and prompted crowds on several occasions.

“What is happening in Brazil is a tragedy that could have been prevented. This tragedy is based on wrong political decisions by the Bolsonaro government,” said German Green Party MEP Anna Cavazzini, vice-chair of the European Parliament Delegation for relations with Brazil.

Prior to the meeting, Cavazzini had blamed the federal government’s “disastrous policies” for the serious situation faced in Brazil. “By encouraging crowds, opposing measures such as contact restrictions and lockdowns, and neglecting to purchase vaccines, Bolsonaro bears responsibility for the catastrophic situation in Brazil.”

Spanish MEP Miguel Urbán Crespo of the Left Group said that the health crisis Brazil is experiencing has political causes, the responsibility for which lies with the current federal government. “Instead of declaring war on the coronavirus, Bolsonaro has declared war on science, medicine, and life,” he stressed.

Crespo also criticized the law passed by Congress and sanctioned by the president that allows the purchase of vaccines against Covid-19 by private companies, which, according to him, should lead to increased prices of vaccines and will benefit only a few. “By action or omission, Bolsonaro’s necropolitics is a crime against humanity, against the Brazilian population,” he stressed.

Spanish MEP Clara Aguilera from the Progressive Alliance of Socialists and Democrats group, also found the approval of legislation allowing private companies to purchase vaccines worrying, and said that this type of measure could have a worldwide impact on the prices of vaccines.

When answering MEPs’ questioning, Galvão refrained from commenting on the criticism and said that Brazil has strong institutions capable of investigating and analyzing the question about responsibilities for alleged errors and omissions in the pandemic.

“We are talking about lives here, let’s leave politics for later. We are not going to save lives today, tomorrow, next week, if we get into a debate that is already happening and will continue to happen. My mission here is to ask you to use your political influence to support a country that has the capacity not only to save itself, but also to help others, because we are industrially strong in vaccine production,” said the ambassador.

Changes in vaccine distribution criteria

Other participants in the debate were Veronique Lorenzo, director of the South America department of the European External Action Service, the diplomatic service of the EU; Sylvan Aldigheri and Socorro Gross Galiano, representatives of the Pan American Health Organization (PAHO), and Camila Asano, program director of Conectas.

In their speech, Aldigheri and Galiano advocated changes in the vaccine distribution criteria by the global consortium led by the WHO Covax Facility so that more doses are sent to the Americas, especially to Brazil. According to them, several countries in the region, especially those in the Southern Cone, are facing a worrying increase in the number of Covid-19 cases, with the spread of the Brazilian coronavirus variant in at least 19 of them.

“For the first time in history, Brazil is facing a collapse in the healthcare system. The country is at the epicenter of the pandemic right now,” said Galiano, the PAHO representative in Brazil. She pointed out that the situation is critical, with shortages of medicines, intubation kits, oxygen and beds. According to her, 10 states have 95% of their ICU beds occupied.

The director of the human rights NGO Conectas criticized the federal policies to fight the pandemic. According to Asano, the Brazilian government’s response can not only be defined by incompetence or omission. “There were proactive measures that did not protect the population and increased the speed of transmission of the virus,” he said, exemplifying with Bolsonaro’s veto of a law passed by Congress that determined the mandatory wearing of masks in public places and the president’s initial refusal to negotiate the purchase of vaccines.

Asano also said that Bolsonaro has waged a campaign against public health by spreading fake news and information without any scientific evidence, encouraging the use of drugs without proven effectiveness, such as hydroxychloroquine, refusing to buy vaccines, and downplaying the pandemic.

“Instead of fighting with all his strength to contain the pandemic, Bolsonaro has increased attacks against democratic institutions, journalists, and civil society,” Asano stressed. “We no longer live in a situation of democratic normality, we ask that the European Parliament continue to closely monitor this situation,” he added.

Source: DW

Read More from The Rio Times

The Rio Times · Power Map
See who really holds power in Latin America
Click to open the Power Map

Rotate for Best Experience

This report is optimized for landscape viewing. Rotate your phone for the full experience.